STAGE IVA OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Clinical trials for STAGE IVA OROPHARYNGEAL SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new STAGE IVA OROPHARYNGEAL SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for STAGE IVA OROPHARYNGEAL SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could less treatment be enough for a common throat cancer?
Disease control CompletedThis study tested a gentler treatment approach for a specific type of throat cancer linked to HPV and not heavy smoking. It enrolled 316 patients with advanced cancer to see if a lower dose of targeted radiation, either with or without the chemotherapy drug cisplatin, could effec…
Matched conditions: STAGE IVA OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: NRG Oncology • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Targeted treatment tested for HPV-Linked throat cancers
Disease control CompletedThis study tested whether giving radiation therapy twice daily along with a chemotherapy drug called docetaxel could better control cancer that returns after surgery for HPV-related throat cancer. The trial involved 81 patients who had their tumors surgically removed but were at …
Matched conditions: STAGE IVA OROPHARYNGEAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC